NCT05219552

Brief Summary

The investigators will recruit 40 pregnant women living with HIV divided into 2 groups (n=20 intervention group, n=20 control group). The intervention group will receive personalized lactation support and monthly unconditional cash transfers (100USD/month) from approximately 30 weeks pregnancy to approximately 6-months postpartum. The control group will receive the current standard care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

February 23, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2023

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

August 14, 2025

Completed
Last Updated

August 14, 2025

Status Verified

July 1, 2025

Enrollment Period

1 year

First QC Date

December 20, 2021

Results QC Date

May 31, 2024

Last Update Submit

July 28, 2025

Conditions

Keywords

Prevention of Mother to Child Transmission of HIV (PMTCT)exclusive breastfeedingWomen Living with HIV (WLWH)financial insecurityfood insecurity

Outcome Measures

Primary Outcomes (6)

  • Maternal Mental Health

    Patient Health Questionnaire-9: scoring ranges from 0-27 with higher scores indicating greater depressive symptoms.

    baseline (20-35 weeks pregnant), 6-weeks postpartum and 6-months postpartum

  • Number of Participants Who Reported Feeding Breastmilk Only

    Breast feeding behavior questionnaires where participants were asked, "What are you currently feeding your baby". The count of participants is the number of participants who selected, "breastmilk only".

    2 weeks, 4 weeks, 6 weeks, and 12 weeks postpartum

  • Number of Participants Who Acknowledge Missing One or More HIV Infant Medications

    Questionnaire on adherence to infant HIV prophylaxis- participant count is the number of participants who acknowledged missing one more more dose of their infant's HIV medications (collected at 6 weeks and 6 months).

    6-weeks postpartum and 6-months postpartum

  • Maternal Adherence to HIV Medications

    Questionnaire on Maternal Adherence to HIV medications- the reported data comes from a visual analog scale where participants were instructed, "Please point or mark at the point showing how much of your ARVs you have taken in the past 30 days."

    baseline (20-35 weeks pregnant), 6-weeks postpartum and 6-months postpartum

  • Food Security

    Household Food Insecurity Access scale: scoring ranges from 0-27 with higher scores indicating greater food insecurity.

    baseline (20-35 weeks pregnant), 6-weeks postpartum and 6-months postpartum

  • Financial Security

    These data were collected qualitatively using in depth exit interviews with intervention only participants to better understand how the cash transfer was used, what changes resulted in their lives related to increased financial security due to the cash transfer.

    7 months

Secondary Outcomes (4)

  • Relationships Status

    baseline (20-35 weeks pregnant), 6-weeks postpartum and 6-months postpartum

  • Women's Empowerment

    baseline (20-35 weeks pregnant), 6-weeks postpartum and 6-months postpartum

  • HIV-related Stigma

    baseline (20-35 weeks pregnant), 6-weeks postpartum and 6-months postpartum

  • Social Support

    6-weeks postpartum and 6-months postpartum

Study Arms (2)

Intervention group- lactation support and unconditional cash transfers

EXPERIMENTAL

Women in this arm will receive personal lactation support from a professional lactation specialist at 5 time points: pregnancy and at 2-weeks, 4-weeks, 6-weeks and 3-months postpartum. Women in the intervention group will also receive monthly unconditional cash transfers of 10,000 Kenyan shillings sent directly to a a mobile phone-based money transfer service accounts associated with their personal cell phone.

Behavioral: personalized lactation support

Control group- standard care

NO INTERVENTION

The women enrolled in the control arm will receive standard care at a clinic similar to, but distinct from, the intervention site.

Interventions

Our intervention design aims to address food insecurity and mental health by providing an unconditional cash transfer and lactation support across the perinatal period, when women are out of the workforce caring for their infant child. The study will include pregnant women living with HIV in Kisumu Kenya. The lactation support component will focus on milk insufficiency primarily as that has been a main concern of women we've worked with in this population, in addition to general breastfeeding support which will all be delivered in one-on-one sessions with a professional lactation consultant. The cash transfer will be delivered to women from their third trimester to 6 months postpartum. The amount of the cash transfer is based on preliminary data and consultation with key stakeholders to determine a reasonable and sufficient amount to basic living expenses during this period.

Also known as: unconditional cash transfers
Intervention group- lactation support and unconditional cash transfers

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • weeks pregnant
  • Living with HIV
  • Currently prescribed antiretroviral therapy (ART)

You may not qualify if:

  • High-risk pregnancy for reasons other than HIV status (e.g., pregnancy complications, preeclampsia, gestational diabetes, preterm labor)
  • Self-reported participation in another ART adherence-related intervention study
  • Unable to understand consent process
  • Planning on relocating out of Nyanza province within 12 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kisumu County Hospital

Kisumu, Kenya

Location

Lumumba Sub-county Hospital

Kisumu, Kenya

Location

Related Publications (4)

  • Tuthill EL, Maltby AE, Odhiambo BC, Akama E, Pellowski JA, Cohen CR, Weiser SD, Conroy AA. "I Found Out I was Pregnant, and I Started Feeling Stressed": A Longitudinal Qualitative Perspective of Mental Health Experiences Among Perinatal Women Living with HIV. AIDS Behav. 2021 Dec;25(12):4154-4168. doi: 10.1007/s10461-021-03283-z. Epub 2021 May 16.

    PMID: 33997940BACKGROUND
  • Haushofer J, Shapiro J. THE SHORT-TERM IMPACT OF UNCONDITIONAL CASH TRANSFERS TO THE POOR: EXPERIMENTAL EVIDENCE FROM KENYA. Q J Econ. 2016 Nov;131(4):1973-2042. doi: 10.1093/qje/qjw025. Epub 2016 Jul 19.

    PMID: 33087990BACKGROUND
  • Maltby AE, Odhiambo BC, Nyaura M, Shikari R, Tuthill EL. Feasibility, acceptability and lessons learned from an infant feeding intervention trial among women living with HIV in western Kenya. BMC Public Health. 2023 Oct 5;23(1):1930. doi: 10.1186/s12889-023-16794-2.

  • Tuthill EL, Maltby AE, Odhiambo BC, Hoffmann TJ, Nyaura M, Shikari R, Cohen CR, Weiser SD. "It has changed my life": unconditional cash transfers and personalized infant feeding support- a feasibility intervention trial among women living with HIV in western Kenya. Int Breastfeed J. 2023 Nov 27;18(1):64. doi: 10.1186/s13006-023-00600-1.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeBreast Feeding

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesFeeding BehaviorBehavior

Results Point of Contact

Title
Dr. Emily Tuthill
Organization
University of California School of Nursing

Study Officials

  • Emily L Tuthill, PhD

    University of California San Fransisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 20 participants recruited to the intervention group at one clinic. 20 participants simultaneously recruited to a control group at a different (but matched) clinic.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2021

First Posted

February 2, 2022

Study Start

February 23, 2022

Primary Completion

March 9, 2023

Study Completion

March 9, 2023

Last Updated

August 14, 2025

Results First Posted

August 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations